Skip to content
10-K

Annual Report

HUBEI MINKANG PHARMACEUTICAL LTD.

0001477932-14-001798

← back to feed
Filed
Apr 15, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2013 · Apr 15, 2014 52.19M sh
Capex FY 2013 · Dec 31, 2013 $204.59K
Operating Cash Flow FY 2013 · Dec 31, 2013 $913.11K
Stockholders Equity FY 2013 · Dec 31, 2013 $11.43M
Current Liabilities FY 2013 · Dec 31, 2013 $10.19M
Total Liabilities FY 2013 · Dec 31, 2013 $10.19M
Current Assets FY 2013 · Dec 31, 2013 $14.6M
Total Assets FY 2013 · Dec 31, 2013 $21.62M
Sga Expense FY 2013 · Dec 31, 2013 $3.22M
Rd Expense FY 2013 · Dec 31, 2013 $81.63K
Net Income FY 2013 · Dec 31, 2013 $127.27K
Operating Income FY 2013 · Dec 31, 2013 $41.95K
Gross Profit FY 2013 · Dec 31, 2013 $6.29M
Revenue FY 2013 · Dec 31, 2013 $14.74M
Cash And Equivalents FY 2013 · Dec 31, 2012 $6.07M